Cancer Epidemiology in Albania: Insights, Challenges, and Future Directions
DOI:
https://doi.org/10.62382/jcbt.v2i3.65Keywords:
Cancer epidemiology, Albania, Cancer burden, Incidence, Mortality, Screening, Public healthAbstract
Background: Cancer is a major cause of morbidity and mortality worldwide. While Albania historically reports a lower cancer incidence than Western Europe, its mortality-to-incidence ratio remains high, suggesting challenges in early detection and treatment access.
Methods: We analyzed data from global and regional cancer databases, national health reports, and literature sources, comparing Albania’s cancer trends with neighboring Balkan countries. The study examined incidence, mortality, risk factors, and screening programs.
Results: Albania’s cancer incidence rate remains lower than the European average, but its mortality rate is disproportionately high. Lung cancer remains the most prevalent, linked to high smoking rates, while breast, stomach, colorectal, and bladder cancers are also significant. Limited national screening programs, late-stage diagnoses, and healthcare disparities contribute to this trend. A major challenge is the lack of a national cancer registry, leading to underreporting and data fragmentation.
Conclusion: Strengthening Albania’s cancer registry, expanding screening programs, and improving oncologic care infrastructure are crucial. Future efforts should focus on cost-effective prevention strategies, improved data collection, and regional collaborations.
Downloads
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, et al. Global Cancer Statistics 2021: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021, 71(3), 209-249. DOI: 10.3322/caac.21660
International Agency for Research on Cancer. GLOBOCAN 2023: Cancer Incidence and Mortality Worldwide. Available at: https://gco.iarc.fr/ (Accessed: 25 January 2025).
Albanian Institute of Public Health. Cancer Statistics Report 2023. Tirana, Albania.
World Health Organization. Eastern Europe Cancer Control Strategy. WHO Regional Office for Europe. 2023. Available at: https://www.who.int/europe/
Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Translational Lung Cancer Research. 2015, 4(4), 327-338. DOI: 10.3978/j.issn.2218-6751.2015.08.04
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians. 2023, 73(1), 17-48. DOI: 10.3322/caac.21763
European Cancer Information System (ECIS). Cancer Incidence and Mortality in Europe. 2023. Available at: https://ecis.jrc.ec.europa.eu
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer mortality burden: The GLOBOCAN 2023 approach. International Journal of Cancer. 2023, 152(5), 1129-1143. DOI: 10.1002/ijc.34091
Albanian Ministry of Health. National Health Strategy 2021-2025. Tirana, Albania.
Allemani C, Matsuda T, Carlo VD, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet. 2018, 391(10125), 1023-1075. DOI: 10.1016/S0140-6736(17)33326-3
Albanian Cancer Registry Initiative. Feasibility Study Report. 2022. Tirana, Albania
Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiology, Biomarkers & Prevention. 2016, 25(1), 16-27. DOI: 10.1158/1055-9965.EPI-15-0578
European Society for Medical Oncology (ESMO). Guidelines for Cancer Screening in Europe. Available at: https://www.esmo.org/guidelines (Accessed: 15 May 2025)
Albanian Ministry of Health and Health Insurance Institute. Cancer-related national reports: National Screening Program Data Report (2023); HPV Vaccination Implementation Report (2023); National Cancer Control Plan 2024-2028. Tirana, Albania
World Health Organization. Global Cancer Prevention and Control Frameworks: Global Report on Tobacco Prevalence (2023); ICD-10 Classification for Oncology; HPV Vaccine Introduction Guidelines (2023). Geneva: WHO. Available at: https://www.who.int/ (Accessed: 15 May 2025)
World Cancer Research Fund. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. 2023. Available at: https://www.wcrf.org/
Global Burden of Disease Cancer Collaboration. Global burden of cancer 2023: A systematic analysis. Lancet. 2023, 401(10378), 2232-2250. DOI: 10.1016/S0140-6736(23)00245-2
International Cancer Screening Network (ICSN). Best Practices for Population-Based Screening. 2023. Available at: https://www.healthscreening.iarc.fr/
American Cancer Society. Global Cancer Facts & Figures 2023. Available at: https://www.cancer.org/research/cancer-facts-statistics.html
European Commission. Cancer Prevention Policies in the European Union - Implementation Report. 2023. Available at: https://health.ec.europa.eu
Hollingsworth AB, Li FY, Morse AN. Lifetime risks for breast cancer are age-discriminatory when used for high-risk screening with MRI. Cancer Epidemiol. 2022, 78, 102122. DOI: 10.1016/j.canep.2022.102122
Raza SH, Hameed Y. ERBB2 as a multifaceted biomarker in head and neck squamous cell carcinoma: In silico and in vitro evidence. Journal of Cancer Biomoleculars and Therapeutics. 2025, 2(1), 1-14. DOI: https://doi.org/10.62382/jcbt.v2i1.19
Hazari V. Emerging roles of tsRNAs: Novel biomarkers and therapeutic targets in gynecological oncology. Journal of Cancer Biomoleculars and Therapeutics. 2025, 2(1), 119-132. DOI: https://doi.org/10.62382/jcbt.v2i1.43
Ali A, Yaz H. Analyzing the mutational landscape of prostate cancer susceptibility genes through next-generation sequencing (NGS) analysis. Journal of Cancer Biomoleculars and Therapeutics. 2024, 1(2), 17-28. DOI: https://doi.org/10.62382/jcbt.v1i2.18
European Commission. Cancer Prevention Policies in the European Union - Implementation Report. 2023. Available at: https://health.ec.europa.eu
National Comprehensive Cancer Network (NCCN). Cancer Prevention Guidelines 2023. Available at: https://www.nccn.org/
European Code Against Cancer - 4th Edition. International Agency for Research on Cancer (IARC); 2023. Available at: https://cancer-code-europe.iarc.fr/
US Preventive Services Task Force (USPSTF). Colorectal Cancer Screening Guidelines 2023. Available at: https://www.uspreventiveservicestaskforce.org/
European Medicines Agency (EMA). HPV Vaccines - Approval and Regulatory Overview. 2023. Available at: https://www.ema.europa.eu (Accessed: 15 May 2025)
International Association of Cancer Registries (IACR). Global Cancer Registration Statistics. 2023.
National Cancer Institute (NCI). Surveillance, Epidemiology, and End Results Program. Available at: https://seer.cancer.gov/
American Society of Clinical Oncology (ASCO). State of Cancer Care in Low-Resource Settings. 2023.
Global HPV Consortium. HPV Burden and Vaccine Uptake Trends. 2023.
European Hematology Association (EHA). Leukemia and Lymphoma Trends in Eastern Europe. 2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jona Prifti, Carmelo Pozzo, Erlin Najtellari, Pier Paolo Piccaluga
This work is licensed under a Creative Commons Attribution 4.0 International License.
